体外診断用酵素の市場規模、シェア、動向分析レポート:酵素タイプ別(ポリメラーゼ&トランスクリプターゼ、プロテアーゼ)、疾患タイプ別、技術タイプ別、最終用途別、地域別、セグメント別予測、2023年~2030年In-vitro Diagnostics Enzymes Market Size, Share & Trends Analysis Report By Enzyme Type (Polymerase & Transcriptase, Proteases), By Disease Type, By Technology Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030 体外診断用酵素市場の成長と動向 Grand View Research, Inc.の最新レポートによると、世界の体外診断用酵素市場規模は、2023年から2030年にかけてCAGR 7.9%で拡大し、2030年には37億米ドルに達する見込みです... もっと見る
1~3営業日
サマリー体外診断用酵素市場の成長と動向Grand View Research, Inc.の最新レポートによると、世界の体外診断用酵素市場規模は、2023年から2030年にかけてCAGR 7.9%で拡大し、2030年には37億米ドルに達する見込みです。臨床疾患の正確で迅速な診断と治療は、最適な臨床結果を得るために不可欠である。注目すべき生体触媒特性により、酵素は幅広い疾患の診断に使用されている。 酵素バイオセンサーの開発は、臨床診断における酵素の有用性を高めている。臨床診断における必要性にもかかわらず、バイオセンサーの商業化と研究から臨床への移行はまだ低い。しかし、研究開発努力の増加に伴い、乳酸、コレステロール、グルコースバイオセンサーが診断用として製品化されている。 プロテアーゼは重要なシグナル伝達タンパク質であり、がん、神経疾患、炎症性疾患、心血管疾患など、いくつかの病理学的プロセスに不可欠である。ポリメラーゼとトランスクリプターゼ酵素は、予測期間中に最も速いCAGRを示すと予想される。さらに、これらの酵素を提供するプレーヤーが多数存在することが、成長を促進すると予想される。Kaneka Eurogentec S.A.、東洋紡株式会社、Sekisui Diagnostics, LLCなどの主要企業は、KOD DNA Polymerase、Taq DNA Polymerase、Tth DNA Polymerase、TTx DNA Polymeraseなど、幅広い種類のポリメラーゼを製造・販売している。 2019年は感染症分野が市場を支配した。COVID-19症例の世界的な急激な増加が、COVID-19診断用診断酵素の採用率を押し上げている。感染症診断のためのリアルタイムPCR、LAMP-PCR(Loop-mediated Isothermal Amplification-PCR)、マルチプレックスPCR、デジタルPCR技術に基づく定性的および定量的分子アッセイの利用可能性の増加が、このセグメントにおける酵素の需要を促進している。 酵素免疫組織化学(IHC)は、より優れたコントラスト比と、標的成分の検出のために複数のステインと使用できる手法の互換性により、組織学に好まれている。体外診断用医薬品(IVD)酵素は、組織検体や体液の分析のために、さまざまな最終用途で使用されている。一日に複数の分析を行う大規模な検査室から、少数の検査を行う小規模なクリニックまで、幅広いエンドユーザーが体外診断(IVD)用酵素を使用している。 北米は2019年に顕著な地域市場に浮上した。がん患者数の増加や生検サンプルの病理組織検査への酵素の採用は、同地域の市場成長を促進すると予想される他の要因の一部である。大規模な対象人口の存在、医療インフラの改善、満たされていない臨床ニーズの高さ、政府のイニシアチブの増加、高度な診断技術のための研究開発活動の増加は、最も速い成長率でアジア太平洋市場を牽引すると予測されている。 同市場の主要企業は、市場での存在感を高めるため、新製品の発売、買収、提携、パートナーシップ、地理的拡大などに取り組んでいる。例えば、2020年6月、Codexis, Inc.はAlphazyme LLCと高忠実度DNAポリメラーゼ、T7 RNAポリメラーゼ、逆転写酵素の製造と共同販売に関する提携契約を締結した。 体外診断用酵素市場レポートハイライト - 酵素タイプ別では、ポリメラーゼと転写酵素が分子診断アッセイへの幅広い応用により、2022年に最大のシェアを占める - 疾患タイプ別では、感染症分野が予測期間を通じて市場を支配する見込み - 技術タイプ別では、がん診断における組織学的アッセイの有用性と、さまざまながん種の罹患率の上昇により、組織学的アッセイセグメントが2022年に最大のシェアを占めた。 - 最終用途別では、病院と診断ラボが2022年の市場を支配した。病院や診断ラボでは、入院患者の増加やがん患者の入院数の増加により、組織病理学や細胞病理学のための生検検体の流入が多い。 - この地域には、Innovative Research、Bio-Rad Laboratories, Inc.、Rockland Immunochemicals, Inc.、MyBioSource.com、RayBiotech, Inc.など、多数の企業が存在するため、2022年には北米が市場全体を支配した。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Enzyme Type 1.1.2. Disease Type 1.1.3. Technology Type 1.1.4. End use 1.1.5. Regional scope 1.1.6. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.4. Information or Data Analysis 1.5. Market Formulation & Validation 1.6. Model Details 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Enzyme type outlook 2.2.2. Disease type outlook 2.2.3. Technology type outlook 2.2.4. End use outlook 2.2.5. Regional outlook 2.3. Competitive Insights Chapter 3. In-Vitro Diagnostics Enzymes Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Market Dynamics 3.3.1. Market driver analysis 3.3.2. Market restraint analysis 3.4. In-Vitro Diagnostics Enzymes Market Analysis Tools 3.4.1. Industry Analysis - Porter’s 3.4.1.1. Supplier power 3.4.1.2. Buyer power 3.4.1.3. Substitution threat 3.4.1.4. Threat of new entrant 3.4.1.5. Competitive rivalry 3.4.2. PESTEL Analysis 3.4.2.1. Political landscape 3.4.2.2. Technological landscape 3.4.2.3. Economic landscape Chapter 4. In-Vitro Diagnostics Enzymes: Product Estimates & Trend Analysis 4.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways 4.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030 4.3. Proteases 4.3.1. Proteases market estimates and forecasts, 2018 to 2030 (USD Million) 4.4. Polymerase & Transcriptase 4.4.1. Polymerase & Transcriptase market estimates and forecasts, 2018 to 2030 (USD Million) 4.5. Ribonuclease 4.5.1. Ribonuclease market estimates and forecasts, 2018 to 2030 (USD Million) 4.6. Others 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 5. In-Vitro Diagnostics Enzymes: Disease Type Estimates & Trend Analysis 5.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways 5.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030 5.3. Infectious Disease 5.3.1. Infectious Disease market estimates and forecasts, 2018 to 2030 (USD Million) 5.3.1.1. COVID -19 Testing 5.3.1.1.1. COVID-19 testing market estimates and forecasts, 2018 to 2030 (USD Million) 5.3.1.2. Hepatitis 5.3.1.2.1. Hepatitis market estimates and forecasts, 2018 to 2030 (USD Million) 5.3.1.3. HIV 5.3.1.3.1. HIV market estimates and forecasts, 2018 to 2030 (USD Million) 5.3.1.4. Others 5.3.1.4.1. Other testing market estimates and forecasts, 2018 to 2030 (USD Million) 5.4. Diabetes 5.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million) 5.5. Oncology 5.5.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million) 5.6. Cardiology 5.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million) 5.7. Nephrology 5.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million) 5.8. Autoimmune Diseases 5.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million) 5.9. Others 5.9.1. Other market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 6. In-Vitro Diagnostics Enzymes: Technology Estimates & Trend Analysis 6.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways 6.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030 6.3. Histology Assays 6.3.1. Histology Assays market estimates and forecasts, 2018 to 2030 (USD Million) 6.4. Molecular Diagnostics 6.4.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million) 6.4.1.1. PCR Assays 6.4.1.1.1. PCR assays market estimates and forecasts, 2018 to 2030 (USD Million) 6.4.1.2. NGS Assays 6.4.1.2.1. NGS assays market estimates and forecasts, 2018 to 2030 (USD Million) 6.4.1.3. Others 6.4.1.3.1. Other market estimates and forecasts, 2018 to 2030 (USD Million) 6.5. Clinical Chemistry 6.5.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 7. In-Vitro Diagnostics Enzymes : End Use Estimates & Trend Analysis 7.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways 7.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030 7.3. Pharma & Biotech 7.3.1. Pharma & Biotech market estimates and forecasts, 2018 to 2030 (USD Million) 7.4. Hospital & Diagnostic Labs 7.4.1. Hospital & Diagnostic Lab market estimates and forecasts, 2018 to 2030 (USD Million) 7.5. Academic Labs 7.5.1. Academic Lab market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 8. In-Vitro Diagnostics Enzymes Market: Regional Estimates & Trend Analysis 8.1. Regional Outlook 8.2. In-Vitro Diagnostics Enzymes Market by Region: Key Marketplace Takeaway 8.3. North America 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.3.2. U.S. 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.3.3. Canada 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4. Europe 8.4.1. U.K. 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.2. Germany 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.3. France 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.4. Italy 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.5. Spain 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.6. Sweden 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.7. Norway 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.8. Denmark 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5. Asia Pacific 8.5.1. Japan 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5.2. China 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5.3. India 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5.4. Australia 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5.5. Thailand 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5.6. South Korea 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.6. Latin America 8.6.1. Brazil 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.6.2. Mexico 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.6.3. Argentina 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.7. MEA 8.7.1. Saudi Arabia 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.7.2. South Africa 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.7.3. UAE 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.7.4. Kuwait 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) Chapter 9. Competitive Landscape 9.1. Recent Developments & Impact Analysis, By Key Market Participants 9.2. Company/Competition Categorization 9.2.1. Merck KGaA 9.2.1.1. Company overview 9.2.1.2. Financial performance 9.2.1.3. Product benchmarking 9.2.1.4. Strategic initiatives 9.2.2. Codexis, Inc. 9.2.2.1. Company overview 9.2.2.2. Financial performance 9.2.2.3. Product benchmarking 9.2.2.4. Strategic initiatives 9.2.3. F. Hoffmann-La Roche Ltd. 9.2.3.1. Company overview 9.2.3.2. Financial performance 9.2.3.3. Product benchmarking 9.2.3.4. Strategic initiatives 9.2.4. Amano Enzymes Inc. 9.2.4.1. Company overview 9.2.4.2. Financial performance 9.2.4.3. Product benchmarking 9.2.4.4. Strategic initiatives 9.2.5. Advanced Enzymes Technologies Ltd. 9.2.5.1. Company overview 9.2.5.2. Financial performance 9.2.5.3. Product benchmarking 9.2.5.4. Strategic initiatives 9.2.6. Biocatalysts Ltd. 9.2.6.1. Company overview 9.2.6.2. Financial performance 9.2.6.3. Product benchmarking 9.2.6.4. Strategic initiatives 9.2.7. Amicogen 9.2.7.1. Company overview 9.2.7.2. Financial performance 9.2.7.3. Product benchmarking 9.2.7.4. Strategic initiatives 9.2.8. Dyadic International 9.2.8.1. Company overview 9.2.8.2. Financial performance 9.2.8.3. Product benchmarking 9.2.8.4. Strategic initiatives 9.2.9. BBI Solutions 9.2.9.1. Company overview 9.2.9.2. Financial performance 9.2.9.3. Product benchmarking 9.2.9.4. Strategic initiatives 9.2.10. Affymetrix 9.2.10.1. Company overview 9.2.10.2. Financial performance 9.2.10.3. Product benchmarking 9.2.10.4. Strategic initiatives 9.2.11. American Laboratories 9.2.11.1. Company overview 9.2.11.2. Financial performance 9.2.11.3. Product benchmarking 9.2.11.4. Strategic initiatives
SummaryIn-vitro Diagnostics Enzymes Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Enzyme Type 1.1.2. Disease Type 1.1.3. Technology Type 1.1.4. End use 1.1.5. Regional scope 1.1.6. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.4. Information or Data Analysis 1.5. Market Formulation & Validation 1.6. Model Details 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Enzyme type outlook 2.2.2. Disease type outlook 2.2.3. Technology type outlook 2.2.4. End use outlook 2.2.5. Regional outlook 2.3. Competitive Insights Chapter 3. In-Vitro Diagnostics Enzymes Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Market Dynamics 3.3.1. Market driver analysis 3.3.2. Market restraint analysis 3.4. In-Vitro Diagnostics Enzymes Market Analysis Tools 3.4.1. Industry Analysis - Porter’s 3.4.1.1. Supplier power 3.4.1.2. Buyer power 3.4.1.3. Substitution threat 3.4.1.4. Threat of new entrant 3.4.1.5. Competitive rivalry 3.4.2. PESTEL Analysis 3.4.2.1. Political landscape 3.4.2.2. Technological landscape 3.4.2.3. Economic landscape Chapter 4. In-Vitro Diagnostics Enzymes: Product Estimates & Trend Analysis 4.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways 4.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030 4.3. Proteases 4.3.1. Proteases market estimates and forecasts, 2018 to 2030 (USD Million) 4.4. Polymerase & Transcriptase 4.4.1. Polymerase & Transcriptase market estimates and forecasts, 2018 to 2030 (USD Million) 4.5. Ribonuclease 4.5.1. Ribonuclease market estimates and forecasts, 2018 to 2030 (USD Million) 4.6. Others 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 5. In-Vitro Diagnostics Enzymes: Disease Type Estimates & Trend Analysis 5.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways 5.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030 5.3. Infectious Disease 5.3.1. Infectious Disease market estimates and forecasts, 2018 to 2030 (USD Million) 5.3.1.1. COVID -19 Testing 5.3.1.1.1. COVID-19 testing market estimates and forecasts, 2018 to 2030 (USD Million) 5.3.1.2. Hepatitis 5.3.1.2.1. Hepatitis market estimates and forecasts, 2018 to 2030 (USD Million) 5.3.1.3. HIV 5.3.1.3.1. HIV market estimates and forecasts, 2018 to 2030 (USD Million) 5.3.1.4. Others 5.3.1.4.1. Other testing market estimates and forecasts, 2018 to 2030 (USD Million) 5.4. Diabetes 5.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million) 5.5. Oncology 5.5.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million) 5.6. Cardiology 5.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million) 5.7. Nephrology 5.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million) 5.8. Autoimmune Diseases 5.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million) 5.9. Others 5.9.1. Other market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 6. In-Vitro Diagnostics Enzymes: Technology Estimates & Trend Analysis 6.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways 6.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030 6.3. Histology Assays 6.3.1. Histology Assays market estimates and forecasts, 2018 to 2030 (USD Million) 6.4. Molecular Diagnostics 6.4.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million) 6.4.1.1. PCR Assays 6.4.1.1.1. PCR assays market estimates and forecasts, 2018 to 2030 (USD Million) 6.4.1.2. NGS Assays 6.4.1.2.1. NGS assays market estimates and forecasts, 2018 to 2030 (USD Million) 6.4.1.3. Others 6.4.1.3.1. Other market estimates and forecasts, 2018 to 2030 (USD Million) 6.5. Clinical Chemistry 6.5.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 7. In-Vitro Diagnostics Enzymes : End Use Estimates & Trend Analysis 7.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways 7.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030 7.3. Pharma & Biotech 7.3.1. Pharma & Biotech market estimates and forecasts, 2018 to 2030 (USD Million) 7.4. Hospital & Diagnostic Labs 7.4.1. Hospital & Diagnostic Lab market estimates and forecasts, 2018 to 2030 (USD Million) 7.5. Academic Labs 7.5.1. Academic Lab market estimates and forecasts, 2018 to 2030 (USD Million) Chapter 8. In-Vitro Diagnostics Enzymes Market: Regional Estimates & Trend Analysis 8.1. Regional Outlook 8.2. In-Vitro Diagnostics Enzymes Market by Region: Key Marketplace Takeaway 8.3. North America 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.3.2. U.S. 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.3.3. Canada 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4. Europe 8.4.1. U.K. 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.2. Germany 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.3. France 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.4. Italy 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.5. Spain 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.6. Sweden 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.7. Norway 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.4.8. Denmark 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5. Asia Pacific 8.5.1. Japan 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5.2. China 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5.3. India 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5.4. Australia 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5.5. Thailand 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.5.6. South Korea 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.6. Latin America 8.6.1. Brazil 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.6.2. Mexico 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.6.3. Argentina 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.7. MEA 8.7.1. Saudi Arabia 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.7.2. South Africa 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.7.3. UAE 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) 8.7.4. Kuwait 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million) Chapter 9. Competitive Landscape 9.1. Recent Developments & Impact Analysis, By Key Market Participants 9.2. Company/Competition Categorization 9.2.1. Merck KGaA 9.2.1.1. Company overview 9.2.1.2. Financial performance 9.2.1.3. Product benchmarking 9.2.1.4. Strategic initiatives 9.2.2. Codexis, Inc. 9.2.2.1. Company overview 9.2.2.2. Financial performance 9.2.2.3. Product benchmarking 9.2.2.4. Strategic initiatives 9.2.3. F. Hoffmann-La Roche Ltd. 9.2.3.1. Company overview 9.2.3.2. Financial performance 9.2.3.3. Product benchmarking 9.2.3.4. Strategic initiatives 9.2.4. Amano Enzymes Inc. 9.2.4.1. Company overview 9.2.4.2. Financial performance 9.2.4.3. Product benchmarking 9.2.4.4. Strategic initiatives 9.2.5. Advanced Enzymes Technologies Ltd. 9.2.5.1. Company overview 9.2.5.2. Financial performance 9.2.5.3. Product benchmarking 9.2.5.4. Strategic initiatives 9.2.6. Biocatalysts Ltd. 9.2.6.1. Company overview 9.2.6.2. Financial performance 9.2.6.3. Product benchmarking 9.2.6.4. Strategic initiatives 9.2.7. Amicogen 9.2.7.1. Company overview 9.2.7.2. Financial performance 9.2.7.3. Product benchmarking 9.2.7.4. Strategic initiatives 9.2.8. Dyadic International 9.2.8.1. Company overview 9.2.8.2. Financial performance 9.2.8.3. Product benchmarking 9.2.8.4. Strategic initiatives 9.2.9. BBI Solutions 9.2.9.1. Company overview 9.2.9.2. Financial performance 9.2.9.3. Product benchmarking 9.2.9.4. Strategic initiatives 9.2.10. Affymetrix 9.2.10.1. Company overview 9.2.10.2. Financial performance 9.2.10.3. Product benchmarking 9.2.10.4. Strategic initiatives 9.2.11. American Laboratories 9.2.11.1. Company overview 9.2.11.2. Financial performance 9.2.11.3. Product benchmarking 9.2.11.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
Grand View Research 社の最新刊レポート
本レポートと同じKEY WORD(enzymes)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/08 10:26 154.13 円 166.76 円 202.76 円 |